Ep192: Kate Haviland on Following the Science to Precision Immunology
The Long Run with Luke Timmerman
00:00
Key Drivers of Avapritinib Success
Kate attributes success to deep patient engagement, strong clinical data at low dose, and diagnostics infrastructure.
Play episode from 01:10:47
Transcript
